Kiusianins A-D (1-4) were isolated from the leaves of a Japanese endemic plant, Tilia kiusiana, together with 14 known compounds. The structures of a new lanostane-type triterpenoid 1 and three new cholestanetype sterols 2-4 were elucidated by spectroscopic methods, including two dimensional (2D) NMR. All the compounds isolated were evaluated for their cytotoxicity against two human cancer cell lines, HeLa and HL-60.
Tilia kiusiana is an endemic Japanese plant species found on the islands of Honshu, Shikoku, and Kyushu in Japan. For our screening program to discover new biologically active compounds from Japanese trees, we have constructed an extracts library having more than one hundred species. All the samples in the library were tested for activity against murine leukemia P388 cells. We investigated the constituents of the leaves of the Japanese tree, Tilia kiusiana MAKINO et. SHIRAS (Tiliaceae), because its methanol extract showed cytotoxic activity against P388 cells at 30 µg/mL. This pharmacological property of T. kiusuana led us to investigate the components of Tilia kiusiana, resulting in the isolation of four new compounds 1-4 named kiusianins A-D.
Herein, we describe the isolation and structure elucidation of kiusianins A-D (1-4) and the cytotoxic evaluation of all the isolated compounds against two human cancer cell lines, cervical cancer cells HeLa and promyelocytic leukemia cells HL-60.
The MeOH extract of the leaves of T. kiusiana was partitioned between n-hexane and 90% MeOH. The MeOH-soluble material was purified by octadecyl silica (ODS) column chromatography followed by silica gel column chromatography and reverse-phase HPLC to afford new triterpene 1 and three new sterols 2-4, together with 3β-hydroxy-cycloart-24-en-26-al (5), 1) oleanolic acid (6), 2) arjunolic acid (7), 3) 2α,3β-dihydroxy-24-nor-4 (23),12-oleanadien-28-oic acid (8), 4) 20-hydroxy-cholest-4-en-3-one (9), guggulsterol III (10), 5, 6) guggulsterol І (11), 5,7) (8R)-3β,6β-hydroxy-cholest-4-en-3-one (12), 8) 3β,5α-dihydroxy-cholest-7-ene-6-one (13), 9) (8R)-3β-8α-dihydroxy-polypoda-13E,17E,21-triene (14) , 10) phytol (15), 11) aphanamol II (16), 12) linarin (17), 13) and (3R,6R,7E)-3-hydroxy-4,7-megastigmadien-9-one (18). H COSY spectrum revealed the presence of four segments; C-1-C-3, C-5-C-7, C-9-C-12, and C-15-C-24 (bold lines in Fig. 2 ). The HMBC correlations (Fig. 1) (Fig. 2) means that 1 is lanostane-type triterpenoid having the same C-24-C-27 side chain as that in previously known compound 5.
1) Furthermore, the nuclear Overhauser effect spectroscopy (NOESY) correlation of H-3/ H-5 and the coupling constant of H-3 (δ H 3.24, dd, J=11.4, 4.1 Hz) indicated that 3-OH was in an equatorial β-orientation. For the other NOESY correlations (Fig. 3) double bond. Thus, the relative configuration of compound 1 was assigned as 3β-hydroxy-lanostane-7,24E-dien-26-al and named kiusianin A.
The molecular formula of compound 2 was established as C 27 H 42 O 2 by HR-EI-MS, indicating seven degrees of unsaturation. The IR spectrum revealed the presence of a hydroxyl group, an α,β-unsaturated ketone and an olefin group at 3410, 1678, and 1631 cm C-NMR, and HMQC spectra of 2 indicated the presence of one ketone carbonyl, two sp 2 quaternary carbons, two sp 3 quaternary carbons, two sp 2 methines, five sp 3 methines, ten methylenes, one oxymethylene, and four methyls. Because three of the seven degrees of unsaturation have been accounted for, it was conducted that compound 2 contained four rings. The spectroscopic data disclosed that compound 2 was closely related to chloestane-4,20(22)-dien-3-one.
15) The only difference was that the olefinic methyl group at C-20 was replaced by a hydroxyl methyl group. This was supported by the HMBC correlation of The NOESY correlations indicated that the relative configuration of 2 was identical to that of cholesterol. An E-geometry for the Δ 20, 22 double bond was evident from the observation of NOE between H-21 and H-23. Thus, the relative configuration of compound 2 was assigned as 21-hydroxy-cholest-4,20-dien-3-one and named kiusianin B.
Compound 3 was formulated as C 27 H 44 O 2 by HR-EI-MS, and its IR spectrum showed the presence of a hydroxyl group, an olefin, and a ketone at 3392, 1732, and 1667 cm −1 , respectively. The NMR data (Tables 1, 2) disclosed that 3 was cholest-7-en-3-one with one hydroxyl group attached. The position of the hydroxyl group was unambiguously as- H COSY cross-peak of H-6/H-7. The NOESY spectrum of 3 showed cross-peaks of H-5/H-9 and H-6, indicating that the hydroxyl group was in a β-configuration. The other NOESY correlations (Fig. 3) showed that the relative configuration of 3 was identical to that of cholesterol. Thus, the relative configuration of compound 3 was elucidated as 6β-hydroxy-cholest-7-en-3-one and named kiusianin C. (Tables 1, 2 ) and HMQC data of compound 4 resembled those of compound 3, except for the presence of an exo-methylene in compound 4. Detailed 2D NMR analysis (HMQC, HMBC) revealed that compound 4 contained a terminal double bond at the C-20 position, in place of the C-20 methyl in compound 3. This was substantiated by the HMBC correlations of the exo-methylene protons (δ H 4.82 and 4.90) to C-17 (δ C 55.9) and C-22 (δ C 37.8). The NOESY data supported that the relative configuration of 4 was the same as that of 3. Thus, the relative configuration of compound 4 was elucidated as 6β-hydroxy-cholest-7,20-diene-3-one and named kiusianin D.
All the compounds isolated in the present phytochemical study were evaluated for cytotoxicity ( Table 3) C-NMR spectra were obtained on Bruker AVANCE 500 with cryo-platoform and AMX500 spectrometer using tetramethylsilane as the internal standard. HR-EI-MS spectrum was obtained on JEOL HX-100 and JEOL JMS-GCMATE spectrometer. UV and IR spectra were obtained on Shimadzu UV-260 and JASCO FT/IR-5300 spectrometers, respectively. Column chromatography was performed using ODS (YMC ODS-AM) and silica gel (Wakogel C-300, Wako Pure Chemical Industries, Ltd. (Osaka, Japan)). MPLC was performed using silica-gel {Lobar 5 mg) . The F1-6 fraction (MeOH, 1.8 g) was separated using fractionated with a silica gel c.c. (CHCl 3 -MeOH, 100 : 0 0 : 100) to obtain six fractions (F3-1-6 ). The F3-2 fraction (410 mg) was separated using silica gel c.c. (CHCl 3 -MeOH, 98 : 2 0 : 100) to obtain four fractions (F4-1-4) . The F4-3 fraction (15 mg) was further purified using HPLC (MeOH-H 2 O, 95 : 5) to isolate 15 (3.3 mg). The F4-3 fraction was further purified using HPLC (MeOH-H 2 O, 95 : 5) to afford kiusianin A (1, 4.3 mg) and 5 (2.6 mg).
The second portion of MeOH extracts (8.4 g) was partitioned between n-hexane and 90% aqueous MeOH. The 90% aqueous MeOH-soluble materials (5.0 g) was subjected to silica gel column chromatography (n-hexane-EtOAc, 80 : 20 0 : 100, and then EtOAc-MeOH, 95 : 5 0 : 100) to obtain fractions (F5-1-13 ). The F5-2 fraction (456 mg) was separated using silica gel c.c. (n-hexane-EtOAc, 90 : 10 0 : 100, and then MeOH) to obtain eight fractions (F6-1-8 ). The F6-1 fraction (120 mg) was separated using silica gel c.c. (CHCl 3 -MeOH, 98 : 2 0 : 100) to obtain five fractions (F7-1-5). The F7-2 fraction (15 mg) was further purified by HPLC (MeOH-H 2 O, 93 : 7) to afford 9 (2.4 mg) and 11 (0.60 mg). The F7-4 fraction was purified using HPLC (MeOH-H 2 O, 90 : 10) to afford 14 (7.5 mg). The F6-3 fraction (95 mg) was subjected to a silica gel c.c. (n-hexane-EtOAc, 70 : 30 0 : 100) to obtain two fractions (F8-1-2) . The F8-1 fraction (63 mg) was separated using HPLC (n-hexane-EtOAc, 70 : 30) to obtain four fractions (F9-1-4) . The F9-2 fraction (7.5 mg) was purified using HPLC (MeOH-H 2 O, 95 : 5) to afford 6 (4.5 mg). The F9-4 fraction Cell Cultures and Cytotoxic Activity The cell lines used in this study were HeLa (human cervical cancer) cells and HL-60 (human promyelocytic leukemia) cells. Both cell lines were purchased from the RIKEN BioResource Center (Tokyo, Japan). HeLa cells were grown as a monolayer in MEM, supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin at 37°C in a humidified atmosphere of 5% CO 2 . HL-60 cells were maintained in RPMI-1640, supplemented with 10% FBS and 1% penicillin-streptomycin at 37°C in a humidified atmosphere of 5% CO 2 . HeLa and HL-60 cells were seeded in 96-well plates at a density 5×10 3 cells/well (90 µL/well) and 8×10 3 cells/well (90 µL/well), respectively. The precultures were incubated for 24 h (HeLa cells) and 2 h (HL-60 cells). The medium containing test compounds (10 µL; final DMSO concentration was 0.2%) was then added, and the cells were incubated for 48 h. The cultures were added to CCK-8 (Cell Counting Kit-8, DOJINDO, Kumamoto, Japan) solution (10 µL) and incubated for 2 h (HeLa cells) and 4 h (HL-60 cells) at 37°C. After incubation, their optical densities at 450 nm were measured using a microplate reader (Model 680, BIO RAD, Japan).
